Precision medicine in PAH

Presented at PVRI 2026 Congress by Vinicio de Jesus Perez, Stanford University

Summary

Genetic evaluation is crucial in precision medicine, especially in Latin America. There is a strong need for genetic panels, education, and collaboration to enhance patient outcomes. Genetics plays a key role in understanding pulmonary hypertension and related conditions. Accessible genetic testing and the integration of genetic counseling into patient care are advocated. Challenges in implementation and the benefits of teleconsultation for genetic evaluation are also discussed.

Generated by AI, edited by PVRI